News & Insights | Clinical & Medical Affairs

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MMS buys Exploristics for modeling tech and expanded reach

Report cards and incentives promote transparency in drug trials, analysis says

Fortrea hired to help prep disease detection AI for FDA review

Guiding AI in plain language summaries for clinical trial results

Alimentiv and PhaseV to use machine learning for GI-focused drug trials

ACRO awards site grants to boost diversity in studies

hVIVO acquires Germany’s CRS for ‘significant European foothold’

EU Clinical Trials Regulation will make drug studies more transparent

Link Medical buys CRST to build Northern European CRO

Study raises transparency concerns about clinical trials involving AI

New industry group to promote multisite networks to sponsors, CROs

Lindus Health raises $55m to advance AI tech, expand team

JPM 2025: ICON, PPD talk trial sector volatility; NVIDA outlines IQVIA accord

Fine-tuned AI could aid trial design and transparency compliance, study says

$165m PE investment sets Caidya on M&A trail

Sponsor trial spending surge will coincide with supplier streamlining

Proposed UK trial rules would increase clinical trial transparency

FDA: Tissue biopsies used in trials must be justified

Veeda rebrands with eye on innovator drug trials

EMA changes transparency rules to emphasize patient and trial staff privacy

Quick Links